{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:14:04Z","timestamp":1783199644419,"version":"3.54.6"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.berh.2024.101962","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T15:50:06Z","timestamp":1718293806000},"page":"101962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["How to treat monogenic SLE?"],"prefix":"10.1016","volume":"38","author":[{"given":"Jonathan","family":"Thuner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Cognard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-5332","authenticated-orcid":false,"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2024.101962_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","article-title":"Systemic lupus erythematosus pathogenesis: interferon and beyond","volume":"41","author":"Caielli","year":"2023","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1191\/0961203306lu2263ed","article-title":"A brief history of twins","volume":"15","author":"Block","year":"2006","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.berh.2024.101962_bib3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.semarthrit.2017.06.007","article-title":"Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort","volume":"47","author":"Ulff-M\u00f8ller","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib4","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/S2665-9913(19)30142-0","article-title":"Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts","volume":"2","author":"Belot","year":"2020","journal-title":"The Lancet Rheumatol"},{"issue":"SI2","key":"10.1016\/j.berh.2024.101962_bib5","doi-asserted-by":"crossref","first-page":"SI210","DOI":"10.1093\/rheumatology\/keac275","article-title":"Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE","volume":"62","author":"Charras","year":"2023","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.berh.2024.101962_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-023-00732-x","article-title":"Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants","volume":"19","author":"Vinuesa","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.berh.2024.101962_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109699","article-title":"Monogenic lupus: tracing the therapeutic implications from single gene mutations","volume":"254","author":"Jia","year":"2023","journal-title":"Clin Immunol"},{"issue":"10","key":"10.1016\/j.berh.2024.101962_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102361","article-title":"Monogenic lupus: dissecting heterogeneity","volume":"18","author":"Omarjee","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4049\/jimmunol.1601445","article-title":"Complement protein C1q enhances macrophage foam cell survival and efferocytosis","volume":"198","author":"Pulanco","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","article-title":"Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity","volume":"166","author":"Sisirak","year":"2016","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.berh.2024.101962_bib11","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2024.101962_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: an update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2024.101962_bib13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/jcm10040626","article-title":"Expanding the role of complement therapies: the case for lupus nephritis","volume":"10","author":"Li","year":"2021","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.berh.2024.101962_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nrrheum.2012.75","article-title":"Complement in the immunopathogenesis of rheumatic disease","volume":"8","author":"Sturfelt","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2024.101962_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/sji.12330","article-title":"Systemic lupus erythematosus \u2013 a disease with A dysregulated type I interferon system","volume":"82","author":"Hagberg","year":"2015","journal-title":"Scand J Immunol"},{"issue":"11","key":"10.1016\/j.berh.2024.101962_bib16","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1111\/febs.15589","article-title":"NET formation - mechanisms and how they relate to other cell death pathways","volume":"288","author":"Rosazza","year":"2021","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib17","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41467-023-37083-x","article-title":"Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus","volume":"14","author":"Gomez-Ba\u00f1uelos","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.berh.2024.101962_bib18","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ng.975","article-title":"Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus","volume":"43","author":"Al-Mayouf","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.berh.2024.101962_bib19","first-page":"38","article-title":"Polyamines and their metabolism: from the maintenance of physiological homeostasis to the mediation of disease","volume":"10","author":"Zahedi","year":"2022","journal-title":"Med Sci"},{"issue":"5612","key":"10.1016\/j.berh.2024.101962_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/267621a0","article-title":"Synthetic polyamines added to cultures containing bovine sera reversibly inhibit in vitro parameters of immunity","volume":"267","author":"Byrd","year":"1977","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.berh.2024.101962_bib21","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1136\/ard-2022-222795","article-title":"Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus","volume":"81","author":"Xu","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0961203317741565","article-title":"Systemic lupus erythematosus with C1q deficiency: treatment with fresh frozen plasma","volume":"27","author":"Ekinci","year":"2018","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.berh.2024.101962_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/096120339300200306","article-title":"Reciprocal changes in complement activity and immune-complex levels during plasma infusion in a C2-deficient SLE patient","volume":"2","author":"Erlendsson","year":"1993","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.berh.2024.101962_bib24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10067-012-1978-4","article-title":"C1q deficiency: identification of a novel missense mutation and treatment with fresh frozen plasma","volume":"31","author":"Topaloglu","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2024.101962_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/rheumatology\/kep387","article-title":"SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience","volume":"49","author":"Mehta","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.101962_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molimm.2016.09.001","article-title":"The production and secretion of complement component C1q by human mast cells","volume":"78","author":"van Schaarenburg","year":"2016","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12185-020-03004-7","article-title":"Bone marrow transplantation from a human leukocyte antigen-mismatched unrelated donor in a case with C1q deficiency associated with refractory systemic lupus erythematosus","volume":"113","author":"Matsumura","year":"2021","journal-title":"Int J Hematol"},{"issue":"557","key":"10.1016\/j.berh.2024.101962_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1773-035X(24)00019-4","article-title":"Une \u00e9tiologie rare de lupus \u00e9ryth\u00e9mateux syst\u00e9mique","volume":"2023","author":"Canet","year":"2023","journal-title":"Revue Francophone des Laboratoires"},{"key":"10.1016\/j.berh.2024.101962_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.berh.2024.101962_bib30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u2019-5\u2019 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.berh.2024.101962_bib31","article-title":"A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients","volume":"13","author":"Eugster","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.berh.2024.101962_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Gene Immun"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib33","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41467-017-01932-3","article-title":"Type I interferon-mediated autoinflammation due to DNase II deficiency","volume":"8","author":"Rodero","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.berh.2024.101962_bib34","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/1756-185X.14826","article-title":"A young boy with rash, arthritis, and developmental delay: monogenic lupus due to DNASE2 gene defect","volume":"26","author":"Basu","year":"2023","journal-title":"Int J Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1172\/JCI78533","article-title":"RNASEH2 mutations: translating insights into therapeutic advances","volume":"125","author":"Pendergraft","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1172\/JCI78001","article-title":"Defective removal of ribonucleotides from DNA promotes systemic autoimmunity","volume":"125","author":"G\u00fcnther","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.berh.2024.101962_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1048002","article-title":"Aicardi\u2013Gouti\u00e8res syndrome with SAMHD1 deficiency can be diagnosed by unscheduled DNA synthesis test","volume":"10","author":"Senju","year":"2022","journal-title":"Front Pediatrics"},{"issue":"16","key":"10.1016\/j.berh.2024.101962_bib38","doi-asserted-by":"crossref","first-page":"E3798","DOI":"10.1073\/pnas.1801213115","article-title":"SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-\u03baB and interferon pathways","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"0","author":"Crow","year":"2015","journal-title":"Am J Med Genet"},{"issue":"6252","key":"10.1016\/j.berh.2024.101962_bib40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.aac7049","article-title":"RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself","volume":"349","author":"Liddicoat","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1665","article-title":"The role of RNA editing enzyme ADAR1 in human disease","volume":"13","author":"Song","year":"2022","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.celrep.2018.03.036","article-title":"Increased RNA editing may provide a source for autoantigens in systemic lupus erythematosus","volume":"23","author":"Roth","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jdermsci.2020.08.008","article-title":"Clinical and serological features of dermatomyositis and systemic lupus erythematosus patients with autoantibodies to ADAR1","volume":"100","author":"Muro","year":"2020","journal-title":"J Dermatol Sci"},{"issue":"4","key":"10.1016\/j.berh.2024.101962_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5152\/eurjrheum.2020.20087","article-title":"Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus","volume":"7","author":"Akbar","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.berh.2024.101962_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109593","article-title":"First reported use of anifrolumab to treat a monogenic interferonopathy (DNASE2 loss of function)","volume":"250","author":"Doroudchi","year":"2023","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1016\/j.berh.2024.101962_bib46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s12519-022-00679-2","article-title":"Clinical spectrum and currently available treatment of type I interferonopathy Aicardi\u2013Gouti\u00e8res syndrome","volume":"19","author":"Dell'Isola","year":"2023","journal-title":"World J Pediatr."},{"issue":"23","key":"10.1016\/j.berh.2024.101962_bib47","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMc1810983","article-title":"Reverse-transcriptase inhibitors in the aicardi\u2013gouti\u00e8res syndrome","volume":"379","author":"Rice","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2024.101962_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1288675","article-title":"Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report","volume":"14","author":"Rossano","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.berh.2024.101962_bib49","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41577-021-00577-0","article-title":"Regulation of the nucleic acid-sensing Toll-like receptors","volume":"22","author":"Lind","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"7909","key":"10.1016\/j.berh.2024.101962_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"issue":"92","key":"10.1016\/j.berh.2024.101962_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi9575","article-title":"Disrupted degradative sorting of TLR7 is associated with human lupus","volume":"9","author":"Mishra","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.berh.2024.101962_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1093208","article-title":"Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus","volume":"14","author":"Wen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2024.101962_bib53","doi-asserted-by":"crossref","unstructured":"Tilstra JS, John S, Gordon RA, et al. B cell\u2013intrinsic TLR9 expression is protective in murine lupus. J Clin Invest. 130(6):3172\u20133187..","DOI":"10.1172\/JCI132328"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib54","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.1038\/s41598-018-27782-7","article-title":"Autoimmune disease associated IFIH1 single nucleotide polymorphism related with IL-18 serum levels in Chinese systemic lupus erythematosus patients","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2024.101962_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102794","article-title":"Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis","volume":"127","author":"Ohto","year":"2022","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1681\/ASN.2022040477","article-title":"Clinical implications of a new DDX58 pathogenic variant that causes lupus nephritis due to RIG-I hyperactivation","volume":"34","author":"Peng","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"6121","key":"10.1016\/j.berh.2024.101962_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type-I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.berh.2024.101962_bib58","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10875-021-00974-z","article-title":"STING-mediated lung inflammation and beyond","volume":"41","author":"Fr\u00e9mond","year":"2021","journal-title":"J Clin Immunol"},{"issue":"12","key":"10.1016\/j.berh.2024.101962_bib59","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1172\/JCI79100","article-title":"Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations","volume":"124","author":"Jeremiah","year":"2014","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.berh.2024.101962_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101530","article-title":"STING mediates lupus via the activation of conventional dendritic cell maturation and plasmacytoid dendritic cell differentiation","volume":"23","author":"Thim-uam","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.berh.2024.101962_bib61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-016-0252-y","article-title":"Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey","volume":"36","author":"Briggs","year":"2016","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.berh.2024.101962_bib62","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1359\/jbmr.2003.18.10.1912","article-title":"TRACP as an osteopontin phosphatase","volume":"18","author":"Andersson","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.berh.2024.101962_bib63","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/ni1327","article-title":"Osteopontin expression is essential for interferon-\u03b1 production by plasmacytoid dendritic cells","volume":"7","author":"Shinohara","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.berh.2024.101962_bib64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaut.2018.07.019","article-title":"Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders","volume":"94","author":"Lu","year":"2018","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105523","article-title":"New biologics and targeted therapies in systemic lupus: from new molecular targets to new indications. A systematic review","volume":"90","author":"Felten","year":"2023","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.berh.2024.101962_bib66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2024.101962_bib67","article-title":"From monogenic lupus to TLR7\/MyD88-targeted therapy","volume":"3","author":"Wang","year":"2022","journal-title":"Innovation"},{"key":"10.1016\/j.berh.2024.101962_bib68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12969-023-00916-6","article-title":"Case report: JAK1\/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy","volume":"21","author":"Wu","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2020.09.002","article-title":"COPA syndrome, 5 years after: where are we?","volume":"88","author":"Fr\u00e9mond","year":"2021","journal-title":"Joint Bone Spine"},{"issue":"37","key":"10.1016\/j.berh.2024.101962_bib70","doi-asserted-by":"crossref","first-page":"20273","DOI":"10.1021\/jacs.3c03637","article-title":"Development of LB244, an irreversible STING antagonist","volume":"145","author":"Barasa","year":"2023","journal-title":"J Am Chem Soc"},{"issue":"7","key":"10.1016\/j.berh.2024.101962_bib71","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/molecules28073127","article-title":"Potential therapeutic value of the STING inhibitors","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.berh.2024.101962_bib72","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.berh.2024.101962_bib73","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.apsb.2020.03.001","article-title":"Small molecules targeting the innate immune cGAS\u2012STING\u2012TBK1 signaling pathway","volume":"10","author":"Ding","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.berh.2024.101962_bib74","article-title":"Janus kinase inhibitors in the treatment of type I interferonopathies: a case series from a single center in China","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib75","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049107","article-title":"The RASopathies: from pathogenetics to therapeutics","volume":"15","author":"Hebron","year":"2022","journal-title":"Dis Model Mech"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.semarthrit.2013.04.009","article-title":"Are RASopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus? Case report and systematic review of the literature","volume":"43","author":"Bader-Meunier","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101962_bib77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12969-019-0346-1","article-title":"RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children","volume":"17","author":"Wang","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.berh.2024.101962_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.652405","article-title":"Activated PI3Kinase delta syndrome\u2014a multifaceted disease","volume":"9","author":"Thouenon","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.berh.2024.101962_bib79","first-page":"57","article-title":"PI3Ks in lymphocyte signaling and development","volume":"346","author":"Okkenhaug","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"10.1016\/j.berh.2024.101962_bib80","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.gendis.2020.04.012","article-title":"Phenotypic characterization of patients with activated PI3K\u03b4 syndrome 1 presenting with features of systemic lupus erythematosus","volume":"8","author":"Wang","year":"2020","journal-title":"Genes Dis"},{"key":"10.1016\/j.berh.2024.101962_bib81","article-title":"Case report: hodgkin lymphoma and refractory systemic lupus erythematosus unveil activated phosphoinositide 3-Kinase-\u03b4 syndrome 2 in an adult patient","volume":"9","author":"Conti","year":"2021","journal-title":"Front Pediatrics"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib82","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2019.01.033","article-title":"Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4+ T cells","volume":"144","author":"Bier","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.berh.2024.101962_bib83","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/cei\/uxac109","article-title":"Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency","volume":"212","author":"Kuehn","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2024.101962_bib84","doi-asserted-by":"crossref","unstructured":"Kuehn HS, Sakovich IS, Niemela JE, et al. Disease-associated AIOLOS variants lead to immune deficiency\/dysregulation by haploinsufficiency and redefine AIOLOS functional domains. J Clin Invest. 134(3):e172573..","DOI":"10.1172\/JCI172573"},{"issue":"4","key":"10.1016\/j.berh.2024.101962_bib85","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bj.2021.06.005","article-title":"The genetic landscape of the FAS pathway deficiencies","volume":"44","author":"Magerus","year":"2021","journal-title":"Biomed J"},{"issue":"3","key":"10.1016\/j.berh.2024.101962_bib86","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.berh.2024.101962_bib87","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"issue":"Pt 3","key":"10.1016\/j.berh.2024.101962_bib88","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/BJ20040704","article-title":"Distinctive activation mechanisms and functions for protein kinase C\u03b4","volume":"384","author":"Steinberg","year":"2004","journal-title":"Biochem J"},{"issue":"6883","key":"10.1016\/j.berh.2024.101962_bib89","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/416865a","article-title":"Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C\u03b4","volume":"416","author":"Miyamoto","year":"2002","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.berh.2024.101962_bib90","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/art.38008","article-title":"Protein kinase c\u03b4 deficiency causes mendelian systemic lupus erythematosus with B cell\u2013defective apoptosis and hyperproliferation","volume":"65","author":"Belot","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2024.101962_bib91","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4049\/jimmunol.2200818","article-title":"mTOR activation underlies enhanced B cell proliferation and autoimmunity in PrkcdG510S\/G510S mice","volume":"210","author":"Moreews","year":"2023","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.berh.2024.101962_bib92","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00011-021-01479-6","article-title":"Analysis of five cases of monogenic lupus related to primary immunodeficiency diseases","volume":"70","author":"Su","year":"2021","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2019.03.025","article-title":"Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1\/IKAROS mutations","volume":"144","author":"Kellner","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.berh.2024.101962_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103442","article-title":"Autoimmune lymphoproliferative syndrome: a disorder of immune dysregulation","volume":"22","author":"Paskiewicz","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.berh.2024.101962_bib95","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12969-018-0278-1","article-title":"Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C \u03b4","volume":"16","author":"Lei","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"7","key":"10.1016\/j.berh.2024.101962_bib96","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10875-016-0323-0","article-title":"Protein kinase C \u03b4: a gatekeeper of immune homeostasis","volume":"36","author":"Salzer","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2024.101962_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106764","article-title":"Effects of AS2819899, a novel selective PI3K\u03b4 inhibitor, in a NZB\/W F1 mouse lupus-like nephritis model","volume":"87","author":"Kaneko","year":"2020","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.berh.2024.101962_bib98","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13223-020-00420-6","article-title":"Activated phosphoinositide 3-kinase delta syndrome 1 and 2 (APDS 1 and APDS 2): similarities and differences based on clinical presentation in two boys","volume":"16","author":"Ewertowska","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"10.1016\/j.berh.2024.101962_bib99","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.berh.2024.101962_bib100","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","article-title":"Early-onset autoimmunity associated with SOCS1 haploinsufficiency","volume":"11","author":"Hadjadj","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.berh.2024.101962_bib101","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.bcp.2010.06.044","article-title":"Expression, biological activities and mechanisms of action of A20 (TNFAIP3)","volume":"80","author":"Verstrepen","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.berh.2024.101962_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.990008","article-title":"Haploinsufficiency of A20 in a Chinese child caused by loss-of-function mutations in TNFAIP3: a case report and review of the literature","volume":"10","author":"Liu","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.berh.2024.101962_bib103","series-title":"Heterozygous RELA mutations cause early-onset systemic lupus erythematosus by hijacking the NF-\u03baB pathway towards transcriptional activation of type-I Interferon genes","author":"Barnabei","year":"2020"},{"key":"10.1016\/j.berh.2024.101962_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127085","article-title":"Case report: novel variants in RELA associated with familial Behcet\u2019s-like disease","volume":"14","author":"An","year":"2023","journal-title":"Front Immunol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T03:33:46Z","timestamp":1727148826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1521694224000330"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101962","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to treat monogenic SLE?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101962"}}